Mikkel A. Algire

8.0k citations

19 papers · 2.8k indexed · 1 hit paper · h-index 16

Impact in

Molecular Biology top 5%
- RNA and protein synthesis mechanisms
- CRISPR and Genetic Engineering
- RNA modifications and cancer
- RNA Research and Splicing
- Microbial Metabolic Engineering and Bioproduction
- Gene Regulatory Network Analysis
Microbiology top 5%

Papers in

Microbiology 4
- Microbial infections and disease research 4
Ecology 7
- Bacteriophages and microbial interactions 7

Co-authors: Jon R. Lorsch David Maag Hamilton O. Smith Daniel G. Gibson Gwynedd A. Benders J. Craig Venter Jayshree Zaveri Clyde A. Hutchison
Journals: Molecular Cell (3 papers)ACS Medicinal Chemistry Letters (2 papers)Science (2 papers)RNA (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
Partner nations: United States United Kingdom Cameroon

In The Last Decade

Mikkel A. Algire

19 papers receiving 2.7k citations

Hit Papers

align trajectories log scale

Complete Chemical Synthesis, Assembly, and Cloning of a Mycoplasma genitalium Genome 2008 · 840 citations

Peers

Countries citing papers authored by Mikkel A. Algire

Since Specialization

Citations

This map shows the geographic impact of Mikkel A. Algire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikkel A. Algire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikkel A. Algire more than expected).

Fields of papers citing papers by Mikkel A. Algire

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikkel A. Algire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikkel A. Algire. The network helps show where Mikkel A. Algire may publish in the future.

Co-authors

The 25 scholars most cited alongside Mikkel A. Algire, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mikkel A. Algire Line = papers co-authored together Mikkel A. Algire links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work
1	Discovery of spirohydantoins as selective, orally bioavailable inhibitors of p300/CBP histone acetyltransferases Bioorganic & Medicinal Chemistry Letters ·Zhiqin Ji, Richard F. Clark, Vikram Bhat, Terkel Hansen, Loren Lasko, Kenneth D. Bromberg, Vlasios Manaves, Mikkel A. Algire, Ruth L. Martin, Wei Qiu, Maricel Torrent, Clarissa G. Jakob, Hong Liu, Philip A. Cole, Ronen Marmorstein, Edward A. Kesicki, Albert Lai, Michael R. Michaelides	2021	16
2	Discovery of a Potent and Selective Covalent p300/CBP Inhibitor ACS Medicinal Chemistry Letters ·Anthony Mastracchio, Chunqiu Lai, Enrico L. DiGiammarino, Damien B. Ready, Loren Lasko, Kenneth D. Bromberg, William J. McClellan, Debra Montgomery, Vlasios Manaves, Bailin Shaw, Mikkel A. Algire, Melanie J. Patterson, Chaohong Sun, Saul H. Rosenberg, Albert Lai, Michael R. Michaelides	2021	15
3	PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone Marrow Molecular Cancer Research ·Todd A. Hopkins, William B. Ainsworth, Paul A. Ellis, Cherrie K. Donawho, Enrico L. DiGiammarino, Sanjay C. Panchal, Vivek C. Abraham, Mikkel A. Algire, Yan Shi, Amanda M. Olson, Eric F. Johnson, Julie L. Wilsbacher, David Maag	2018	173
4	Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2 ACS Medicinal Chemistry Letters ·Ramzi F. Sweis, Zhi Wang, Mikkel A. Algire, C.H. Arrowsmith, Peter J. Brown, Gary G. Chiang, Jun Guo, Clarissa G. Jakob, Sidney H. Kennedy, Fengling Li, David Maag, Bailin Shaw, Nirupama B. Soni, Masoud Vedadi, William N. Pappano	2015	48
5	Restrictionless Cloning Methods in enzymology on CD-ROM/Methods in enzymology ·Mikkel A. Algire	2013	1
6	A Type III restriction–modification system in Mycoplasma mycoides subsp. capri Open Biology ·Mikkel A. Algire, Michael Montague, Sanjay Vashee, Carole Lartigue, Chuck Merryman	2012	10
7	The 5′-7-Methylguanosine Cap on Eukaryotic mRNAs Serves Both to Stimulate Canonical Translation Initiation and to Block an Alternative Pathway Molecular Cell ·Sarah F. Mitchell, Sarah E. Walker, Mikkel A. Algire, Eun-Hee Park, Alan G. Hinnebusch, Jon R. Lorsch	2010	106
8	Cloning whole bacterial genomes in yeast Nucleic Acids Research ·Gwynedd A. Benders, Vladimir N. Noskov, Evgeniya A. Denisova, Carole Lartigue, Daniel G. Gibson, Nacyra Assad-Garcia, Ray-Yuan Chuang, William Carrera, Monzia Moodie, Mikkel A. Algire, Quang N. Phan, Nina Alperovich, Sanjay Vashee, Chuck Merryman, J. Craig Venter, Hamilton O. Smith, John I. Glass, Clyde A. Hutchison	2010	105
9	Creating Bacterial Strains from Genomes That Have Been Cloned and Engineered in Yeast Science ·Carole Lartigue, Sanjay Vashee, Mikkel A. Algire, Ray-Yuan Chuang, Gwynedd A. Benders, Li Ma, Vladimir N. Noskov, Evgeniya A. Denisova, Daniel G. Gibson, Nacyra Assad-Garcia, Nina Alperovich, David W. Thomas, Chuck Merryman, Clyde A. Hutchison, Hamilton O. Smith, J. Craig Venter, John I. Glass	2009	208
10	New Selectable Marker for Manipulating the Simple Genomes of Mycoplasma Species Antimicrobial Agents and Chemotherapy ·Mikkel A. Algire, Carole Lartigue, David W. Thomas, Nacyra Assad-Garcia, John I. Glass, Chuck Merryman	2009	20
11	Complete Chemical Synthesis, Assembly, and Cloning of a Mycoplasma genitalium Genome Science ·Daniel G. Gibson, Gwynedd A. Benders, Cynthia Andrews‐Pfannkoch, Evgeniya A. Denisova, Holly Baden-Tillson, Jayshree Zaveri, Timothy B. Stockwell, Anushka Brownley, David W. Thomas, Mikkel A. Algire, Chuck Merryman, Lei Young, Vladimir N. Noskov, John I. Glass, J. Craig Venter, Clyde A. Hutchison, Hamilton O. Smith Hit paper breakdown →	2008	840
12	One-step assembly in yeast of 25 overlapping DNA fragments to form a complete synthetic Mycoplasma genitalium genome Proceedings of the National Academy of Sciences ·Daniel G. Gibson, Gwynedd A. Benders, Kevin Axelrod, Jayshree Zaveri, Mikkel A. Algire, Monzia Moodie, Michael Montague, J. Craig Venter, Hamilton O. Smith, Clyde A. Hutchison	2008	354
13	N‐ and C‐terminal residues of eIF1A have opposing effects on the fidelity of start codon selection The EMBO Journal ·Christie A. Fekete, Sarah F. Mitchell, Vera Cherkasova, Drew J. Applefield, Mikkel A. Algire, David Maag, Adesh K. Saini, Jon R. Lorsch, Alan G. Hinnebusch	2007	96
14	The Eukaryotic Translation Initiation Factors eIF1 and eIF1A Induce an Open Conformation of the 40S Ribosome Molecular Cell ·Lori A. Passmore, T.M. Schmeing, David Maag, Drew J. Applefield, Michael Acker, Mikkel A. Algire, Jon R. Lorsch, V. Ramakrishnan	2007	255
15	Dissociation of eIF1 from the 40S ribosomal subunit is a key step in start codon selection in vivo Genes & Development ·Yuen-Nei Cheung, David Maag, Sarah F. Mitchell, Christie A. Fekete, Mikkel A. Algire, Julie E. Takacs, Nikolay E. Shirokikh, Tatyana V. Pestova, Jon R. Lorsch, Alan G. Hinnebusch	2007	131
16	Where to begin? The mechanism of translation initiation codon selection in eukaryotes Current Opinion in Chemical Biology ·Mikkel A. Algire, Jon R. Lorsch	2006	21
17	Pi Release from eIF2, Not GTP Hydrolysis, Is the Step Controlled by Start-Site Selection during Eukaryotic Translation Initiation Molecular Cell ·Mikkel A. Algire, David Maag, Jon R. Lorsch	2005	192
18	Communication between Eukaryotic Translation Initiation Factors 5 and 1A within the Ribosomal Pre-initiation Complex Plays a Role in Start Site Selection Journal of Molecular Biology ·David Maag, Mikkel A. Algire, Jon R. Lorsch	2005	68
19	Development and characterization of a reconstituted yeast translation initiation system RNA ·Mikkel A. Algire, David Maag, PETER SAVIO, Michael Acker, Salvador Z. Tarun, Alan B. Sachs, Katsura Asano, Klaus Nielsen, DEANNE S. OLSEN, Lon Phan, Alan G. Hinnebusch, Jon R. Lorsch	2002	122

About Mikkel A. Algire

Mikkel A. Algire is a scholar working on Microbiology, Ecology, Molecular Biology, Plant Science and Cardiology and Cardiovascular Medicine, having authored 19 papers that have together received 2.8k indexed citations. Recurring topics across this work include RNA and protein synthesis mechanisms (8 papers), Bacteriophages and microbial interactions (7 papers), RNA Research and Splicing (6 papers), RNA modifications and cancer (5 papers), Plant Virus Research Studies (4 papers), Microbial infections and disease research (4 papers), CRISPR and Genetic Engineering (3 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Molecular Biology (2.4k citations), Microbiology (120 citations), Genetics (504 citations), Ecology (305 citations) and Biotechnology (64 citations). Mikkel A. Algire has collaborated with scholars based in United States, United Kingdom and Cameroon. Frequent co-authors include Jon R. Lorsch, David Maag, Hamilton O. Smith, Daniel G. Gibson, Gwynedd A. Benders, J. Craig Venter, Jayshree Zaveri, Clyde A. Hutchison, Chuck Merryman and John I. Glass. Their work appears in journals such as Molecular Cell, ACS Medicinal Chemistry Letters, Science, RNA and Bioorganic & Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact